Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MARAVAI LIFESCIENCES HOLDINGS, INC. | Director | Class A Common Stock | 80.8K | $871K | $10.78 | May 23, 2024 | Direct |
Morphic Holding, Inc. | Director | Common Stock | 23.2K | $637K | $27.49 | Jun 4, 2024 | Direct |
Theravance Biopharma, Inc. | Director | Ordinary Shares | 31.5K | $272K | $8.64 | May 8, 2024 | Direct |
Theravance Biopharma, Inc. | Director | Share Option (Right to Buy) | 23.6K | May 8, 2024 | Direct | ||
4D Molecular Therapeutics, Inc. | Director | Stock Option (Right To Buy) | 22.5K | May 21, 2024 | Direct | ||
Apria, Inc. | Director | Restricted Stock Units | 0 | $37.50 | Mar 29, 2022 | Direct | |
Morphic Holding, Inc. | Director | Stock Option (Right to Buy) | 0 | Aug 16, 2024 | Direct |